|
|
Effect of Qiling Yinao Decoction on the expression of nod-like receptor protein 3 in inflammasome of Alzheimer′s disease mice |
LI Yang1 FEI Hongxin2 ZHANG Xiaojie1,3 |
1.School of Basic Medical Sciences, Jiamusi University, Heilongjiang Province, Jiamusi 154002, China;
2.School of Nursing and Rehabilitation, Xinyu University, Jiangxi Province, Xinyu 338004, China;
3.Institute of Pathology, Qiqihar Medical University, Heilongjiang Province, Qiqihar 161000, China |
|
|
Abstract Objective To investigate the effect of Qiling Yinao Decoction (QYD) on the expressions of nod-like receptor protein 3 (NLRP3) in inflammatory microglia of Alzheimer′s disease (AD) mice. Methods According to the random number table method, 24 male APP/PS1 dual-transgenic mice were divided into the QYD experimental group (18.330 g/kg), Donepezil group (0.001 g/kg) and model group, with 8 mice in each group. And 8 mice of the same litter and the same sex were divided into the control group. Model group and control group were given 2 mL/time of normal saline, and gavage treatment for 30 d. Morris water maze was used to test the learning and memory ability of APP/PS1 dual-transgenic mice. Transmission electron microscope was used to observe the changes of microglia cells in the cerebral cortex of mice. Immunohistochemistry and real-time quantitative polymerase chain reaction (RT-qPCR) were used to detect the expressions of NLRP3 in microglia cells in cerebral cortex and β-amyloid (Aβ) in hippocampus. Results Compared with the model group, the ability of learning and memory in QYD group and Donepezil group was significantly improved (all P < 0.05). Compared with the model group, the structure of microglia in cerebral cortex in QYD group and Donepezil group was significantly improved. Compared with the model group, the expression of NLRP3 in cerebral cortex and Aβ mRNA in hippocampus of QYD group and Donepezil group were significantly decreased (P < 0.05). Conclusion QYD can improve the learning and memory ability of AD mice by reducing the expression of NLRP3 in microglia cells in the cerebral cortex of AD mice.
|
|
|
|
|
[1] Krell-Roesch J,Vassilaki M,Mielke MM,et al. Cortical β-amyloid burden, neuropsychiatric symptoms and cognitive status the Mayo Clinic Study of Aging [J]. Transl Psychiatry,2019,9(1):123.
[2] Tackenberg C,Nitsch RM. The secreted APP ectodomain sAPPα,but not sAPPβ protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation [J]. Mol Brain,2019,12(1):27.
[3] Li L,Ismael S,Nasoohi S,et al. Thioredoxin-Interacting Protein(TXNIP)Associated NLRP3 Inflammasome Activation in Human Alzheimer′s Disease Brain [J]. J Alzheimers Dis,2019,68(1):255-265.
[4] Stancu IC,Cremers N,Vanrusselt H,et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo [J]. Acta Neuropathol,2019,137(4):599-617.
[5] Jin X,Liu MY,Zhang DF,et al. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway [J]. CNS Neurosci Ther,2019,25(5):575-590.
[6] Bai H,Zhang QF,Duan JJ,et al. Downregulation of signal transduction and STAT3 expression exacerbates oxidative stress mediated by NLRP3 inflammasome [J]. Neural Regen Res,2018,13(12):2147-2155.
[7] Cai H,Luo Y,Yan X,et al. The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer′s Disease [J]. Sci Rep,2018,8(1):3104.
[8] Ong WY,Wu YJ,Farooqui T,et al. Qi Fu Yin-a Ming Dynasty Prescription for the Treatment of Dementia [J]. Mol Neurobiol,2018,55(9):7389-7400.
[9] 汪白云,刘国良,朴成玉,等.基于网络药理学的补阳还五汤防治阿尔茨海默病的机制研究[J].中国医药导报,2019,16(6):12-15.
[10] 张继,陈德昌,林惠蓉,等.中国中药材真伪鉴别图典[D].3版.广州:广东科技出版社,2011.
[11] 龙清华,丁莉,赵宾宾,等.酸枣仁汤通过抑制APP/PS1双转基因小鼠海马神经炎症发挥神经保护作用[J].中国实验方剂学杂志,2019,25(20):1-6.
[12] Hu W,Wen L,Cao F,et al. Down-Regulation of Mir-107 Worsen Spatial Memory by Suppressing SYK Expression and Inactivating NF-ΚB Signaling Pathway [J]. Curr Alzheimer Res,2019,16(2):135-145.
[13] Yang B,Cai Z,Zhang W,et al. Autophagy alleviates the decrease in proliferation of amyloid β142 treated bone marrow mesenchymal stem cells via the AKT/mTOR signaling pathway [J]. Mol Med Rep,2019,19(5):4091-4100.
[14] Chen FJ,Liu B,Wu Q,et al. Icariin Delays Brain Aging in Senescence-Accelerated Mouse Prone 8(SAMP8) Model via Inhibiting Autophagy [J]. J Pharmacol Exp Ther,2019,369(1):121-128.
[15] Miyazaki H,Okamoto Y,Motoi A,et al. Adzuki bean(Vigna angularis)extract reduces amyloid-β aggregation and delays cognitive impairment in Drosophila models of Alzheimer′s disease [J]. Nutr Res Pract,2019,13(1):64-69.
[16] 黄飞娟,程德金,吴正治,等.阿尔茨海默病病理鼠模型研究进展[J].医学综述,2017,23(24):4851-4857.
[17] Yang Y,Wang H,Kouadir M,et al. Recent advances in the mechanisms of NLRP3 in flammasome activation and its inhibitors [J]. Cell Death Dis,2019,10(2):128.
[18] Gong G,Qi B,Liang YT,et al. Danggui Buxue Tang an ancient Chinese herbal decoction protects β-amyloid-induced cell death in cultured cortical neurons [J]. BMC Complement Altern Med,2019,19(1):9.
[19] Hishimoto A,Pletnikova O,Lang DL,et al. Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer′s disease [J]. Alzheimers Res Ther,2019, 11(1):28.
[20] Qi Y,Shang L,Liao Z,et al. Intracerebroventricular injection of resveratrol ameliorated Aβ-induced learning and cognitive decline in mice [J]. Metab Brain Dis,2019, 34(1):257-266.
[21] Wang L,Wang Y,Wang Z,et al. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3inflammasome activation [J]. Am J Physiol Gastrointest Liver Physiol,2018,315(6):G909-G920.
[22] Ebrahimi T,Rust M,Kaiser SN,et al. α1-antitrypsin mitigates NLRP3 inflammasome activation in amyloid β1-42-stimulated murine astrocytes [J]. J Neuroinflammation,2018,15(1):282.
[23] 付昱,王祎,李昕,等.小胶质细胞在神经血管单元中的作用及其在缺血损伤中相关反应的研究进展[J].医学综述,2018,24(23):4678-4682,4688.
[24] Zeng QZ,Yang F,Li CG,et al. Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages [J]. Front Immunol,2019,10:72. |
|
|
|